Mepolizumab

Entity type image
Type: Product
Name: Mepolizumab
First reported Apr 05 2013 - Updated Apr 05 2013 - 1 reports
GlaxoSmithKline plc
GlaxoSmithKline plc

Orphan designation: Mepolizumab, for the: Treatment of Churg-Strauss syndrome

On 12 March 2013, orphan designation (EU/3/13/1116) was granted by the European Commission to Glaxo Group Ltd, United Kingdom, for mepolizumab for the treatment of Churg-Strauss syndrome. ... [Published Orphan designations - Apr 05 2013]

More Content

All (2) | News (0) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - May 03 2013]
Orphan designation: Mepolizumab, for the: Treat... [Published Orphan designations - Apr 05 2013]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - May 03 2013]
Orphan designation: Mepolizumab, for the: Treat... [Published Orphan designations - Apr 05 2013]
On 12 March 2013, orphan designation (EU/3/13/1116) was granted by the European Commission to Glaxo Group Ltd, United Kingdom, for mepolizumab for the treatment of Churg-Strauss syndrome. ...
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.